Literature DB >> 22675659

Proteolytic degradation of amyloid β-protein.

Takaomi Saido1, Malcolm A Leissring.   

Abstract

The amyloid β-protein (Aβ) is subject to proteolytic degradation by a diverse array of peptidases and proteinases, known collectively as Aβ-degrading proteases (AβDPs). A growing number of AβDPs have been identified, which, under physiological and/or pathophysiological conditions, contribute significantly to the determination of endogenous cerebral Aβ levels. Despite more than a decade of investigation, the complete set of AβDPs remains to be established, and our understanding of even well-established AβDPs is incomplete. Nevertheless, the study of known AβDPs has contributed importantly to our understanding of the molecular pathogenesis of Alzheimer disease (AD) and has inspired the development of several novel therapeutic approaches to the regulation of cerebral Aβ levels. In this article, we discuss the general features of Aβ degradation and introduce the best-characterized AβDPs, focusing on their diverse properties and the numerous conceptual insights that have emerged from the study of each.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22675659      PMCID: PMC3367539          DOI: 10.1101/cshperspect.a006379

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  115 in total

Review 1.  Immunological origin and functional properties of catalytic autoantibodies to amyloid beta peptide.

Authors:  Sudhir Paul; Stephanie Planque; Yasuhiro Nishiyama
Journal:  J Clin Immunol       Date:  2010-05       Impact factor: 8.317

2.  Neprilysin degrades both amyloid beta peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases.

Authors:  K Shirotani; S Tsubuki; N Iwata; Y Takaki; W Harigaya; K Maruyama; S Kiryu-Seo; H Kiyama; H Iwata; T Tomita; T Iwatsubo; T C Saido
Journal:  J Biol Chem       Date:  2001-03-06       Impact factor: 5.157

3.  Loss of neprilysin function promotes amyloid plaque formation and causes cerebral amyloid angiopathy.

Authors:  Wesley Farris; Sonja G Schütz; John R Cirrito; Ganesh M Shankar; Xiaoyan Sun; Ana George; Malcolm A Leissring; Dominic M Walsh; Wei Qiao Qiu; David M Holtzman; Dennis J Selkoe
Journal:  Am J Pathol       Date:  2007-07       Impact factor: 4.307

4.  Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation.

Authors:  Takashi Saito; Nobuhisa Iwata; Satoshi Tsubuki; Yoshie Takaki; Jiro Takano; Shu-Ming Huang; Takahiro Suemoto; Makoto Higuchi; Takaomi C Saido
Journal:  Nat Med       Date:  2005-03-20       Impact factor: 53.440

5.  Matrix metalloproteinase-9 degrades amyloid-beta fibrils in vitro and compact plaques in situ.

Authors:  Ping Yan; Xiaoyan Hu; Haowei Song; Kejie Yin; Randall J Bateman; John R Cirrito; Qingli Xiao; Fong F Hsu; John W Turk; Jan Xu; Chung Y Hsu; David M Holtzman; Jin-Moo Lee
Journal:  J Biol Chem       Date:  2006-06-20       Impact factor: 5.157

6.  Degradation of intraendosomal insulin by insulin-degrading enzyme without acidification.

Authors:  F G Hamel; M J Mahoney; W C Duckworth
Journal:  Diabetes       Date:  1991-04       Impact factor: 9.461

7.  Identification of amino acid residues of the matrix metalloproteinase-2 essential for its selective inhibition by beta-amyloid precursor protein-derived inhibitor.

Authors:  Shouichi Higashi; Kaoru Miyazaki
Journal:  J Biol Chem       Date:  2008-01-31       Impact factor: 5.157

8.  Aggregation and catabolism of disease-associated intra-Abeta mutations: reduced proteolysis of AbetaA21G by neprilysin.

Authors:  Vicki Betts; Malcolm A Leissring; Georgia Dolios; Rong Wang; Dennis J Selkoe; Dominic M Walsh
Journal:  Neurobiol Dis       Date:  2008-06-17       Impact factor: 5.996

9.  Insulin-degrading enzyme is exported via an unconventional protein secretion pathway.

Authors:  Ji Zhao; Lilin Li; Malcolm A Leissring
Journal:  Mol Neurodegener       Date:  2009-01-14       Impact factor: 14.195

10.  Reducing amyloid plaque burden via ex vivo gene delivery of an Abeta-degrading protease: a novel therapeutic approach to Alzheimer disease.

Authors:  Matthew L Hemming; Michaela Patterson; Casper Reske-Nielsen; Ling Lin; Ole Isacson; Dennis J Selkoe
Journal:  PLoS Med       Date:  2007-08       Impact factor: 11.069

View more
  126 in total

Review 1.  Deciphering Alzheimer disease.

Authors:  Dennis Selkoe; Eckhard Mandelkow; David Holtzman
Journal:  Cold Spring Harb Perspect Med       Date:  2012-01       Impact factor: 6.915

Review 2.  Biochemistry of amyloid β-protein and amyloid deposits in Alzheimer disease.

Authors:  Colin L Masters; Dennis J Selkoe
Journal:  Cold Spring Harb Perspect Med       Date:  2012-06       Impact factor: 6.915

3.  Aβ truncated species: Implications for brain clearance mechanisms and amyloid plaque deposition.

Authors:  Erwin Cabrera; Paul Mathews; Emiliya Mezhericher; Thomas G Beach; Jingjing Deng; Thomas A Neubert; Agueda Rostagno; Jorge Ghiso
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-07-13       Impact factor: 5.187

4.  Newfound effect of N-acetylaspartate in preventing and reversing aggregation of amyloid-beta in vitro.

Authors:  Jean-Pierre Dollé; Jeffrey M Rodgers; Kevin D Browne; Thomas Troxler; Feng Gai; Douglas H Smith
Journal:  Neurobiol Dis       Date:  2018-05-31       Impact factor: 5.996

5.  Overexpression of the Insulin-Like Growth Factor II Receptor Increases β-Amyloid Production and Affects Cell Viability.

Authors:  Y Wang; V Buggia-Prévot; M E Zavorka; R C Bleackley; R G MacDonald; G Thinakaran; S Kar
Journal:  Mol Cell Biol       Date:  2015-05-04       Impact factor: 4.272

6.  Amyloid-β Derived from the Brain of the Alzheimer's Disease Transgenic Mouse Is Resistant to Proteolytic Digestion Due to Its Conformation.

Authors:  Baian Chen; Jing Zhang; Shubo Wang; Wen Wang; Zitong Yao; Quan Sun; Yi Wu; Jing Lu
Journal:  J Mol Neurosci       Date:  2017-07-19       Impact factor: 3.444

Review 7.  ApoE and Aβ in Alzheimer's disease: accidental encounters or partners?

Authors:  Takahisa Kanekiyo; Huaxi Xu; Guojun Bu
Journal:  Neuron       Date:  2014-02-19       Impact factor: 17.173

8.  A lipoprotein receptor cluster IV mutant preferentially binds amyloid-β and regulates its clearance from the mouse brain.

Authors:  Abhay P Sagare; Robert D Bell; Alaka Srivastava; Jesse D Sengillo; Itender Singh; Yoichiro Nishida; Nienwen Chow; Berislav V Zlokovic
Journal:  J Biol Chem       Date:  2013-04-11       Impact factor: 5.157

9.  Molecular basis of substrate recognition and degradation by human presequence protease.

Authors:  John V King; Wenguang G Liang; Kathryn P Scherpelz; Alexander B Schilling; Stephen C Meredith; Wei-Jen Tang
Journal:  Structure       Date:  2014-06-12       Impact factor: 5.006

10.  The ubiquitin-proteasome system and the autophagic-lysosomal system in Alzheimer disease.

Authors:  Yasuo Ihara; Maho Morishima-Kawashima; Ralph Nixon
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.